About
Mimetogen develops clinical-stage mRNA cell therapies targeting autoimmune diseases.
Explore Mimetogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Mimetogen develops clinical-stage mRNA cell therapies targeting autoimmune diseases.
Funding rounds, investor list, and risk signals — unlock with a subscription.